Catalyst Oncology

Catalyst Oncology

Catalyst Oncology is a full-service, specialty contract research organization (CRO) built to serve the global biotech industry. Backed by leading retention rates and a culture rooted in its core values, Catalyst Oncology provides customers with teams experienced across all functions, knowledgeable in complex drug classes and study designs, and with data-centric methodologies that help bring next-generation therapies to cancer patients.

Catalyst is a portfolio company of QHP Capital, a leading healthcare and life sciences investment firm.

Biotechnology, Clinical Research, Clinical Trials, Consulting Services, Drug Development

Yes